Skip to main content
OpenTrials
Not yet recruiting

NCT Number: NCT07810621

Post-Induction Low Cardiac Output Syndrome in Coronary Artery Bypass Graft Surgery

Hemodynamic change after induction of general anesthesia is usually judged from mean arterial pressure. Pressure, however, is a surrogate for flow, and the two can separate: cardiac output may fall while arterial pressure remains apparently adequate. The interval that follows induction of anesthesia, before surgical stimulation begins and while hemodynamic conditions are determined by anesthetic management alone, has not been characterized in terms of flow. This study is designed to define post-induction low cardiac output (PiLCOs) in patients undergoing coronary artery bypass grafting.

This is a prospective, observational, two-centre cohort study. Consecutive adults undergoing isolated coronary artery bypass grafting with cardiopulmonary bypass at two tertiary cardiovascular surgery centre will be enrolled. No aspect of anesthetic or surgical management will be altered for the purposes of the study. An arterial catheter is sited before induction while the patient is awake, and cardiac index is recorded continuously at 30-second intervals by arterial waveform analysis. Mean arterial pressure, heart rate, stroke volume index and cardiac index are recorded at the same resolution.

The analysis window is the 30 minutes that follow induction of anesthesia. The period of cardiopulmonary bypass is excluded from all analyses, because flow during bypass is generated by the pump rather than by the heart.

The primary outcome has two components, both defined over that window and both referenced to a cardiac index threshold of 2.0 L/min/m2. The first is the total time spent below threshold, in minutes. The second is the cumulative low-output burden, defined as the integral over time of the difference between the threshold and the measured cardiac index, taken only where that difference is positive. Dimensional analysis reduces the unit of burden to L/m2, a body-surface-indexed volume of undelivered flow, which multiplied by body surface area yields an absolute flow deficit in liters. Time below threshold describes how long the exposure lasts and cumulative burden describes how deep it is. The two together define the exposure, and neither alone is sufficient.

Secondary outcomes are the same two measures computed at cardiac index thresholds of 2.2 and 2.5 L/min/m2; the incidence of PiLCOs, defined as at least one measurement below 2.0 L/min/m2 within the window; the time-weighted average depth across the window and the median depth sustained while below threshold; the distribution of cumulative burden across the three consecutive ten-minute segments of the window; and the time from induction to the first measurement below threshold.

Exploratory analyses will examine the association between the presence and the magnitude of PiLCOs and the postoperative course, including acute kidney injury, serum lactate, duration of mechanical ventilation, intensive care unit and hospital length of stay, and mortality. All outcome analyses are treated as exploratory and hypothesis-generating, and no adjustment is made for multiple comparisons.

Sample size was derived from an internal pilot of 30 patients, comprising the first 15 consecutive patients enrolled at each centre. In that pilot the standard deviation of time below threshold was 8.14 min and the incidence of PiLCOs was 70.0%. Setting the half-width of the 95% confidence interval at 1.7 min for mean time below threshold requires 88 patients, and setting it at 9.5 percentage points for incidence requires 90; the larger figure was carried forward and rounded to 90, allocated as 45 patients per centre. Allowing 15% for withdrawal, protocol deviation and unusable recordings gives a planned enrollment of 104 patients. Because the study estimates the frequency and the magnitude of an event that has not previously been characterized, rather than testing a prespecified superiority hypothesis, sample size is based on the precision of estimation rather than on power.

Not yet recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Ankara Bilkent City Hospital, Ankara, Turkey (Türkiye)

Loading trial locations.

About this study

BACKGROUND AND RATIONALE

Peri-operative hemodynamic management is built almost entirely around arterial pressure. International consensus recommends that mean arterial pressure be kept at or above 60-65 mmHg in patients at risk, notes that organ injury depends on both the depth and the duration of hypotension, and identifies the area beneath a pressure threshold as the metric most closely associated with injury. That framework arose from a large observational literature linking intra-operative hypotension to acute kidney injury, myocardial injury and death.

Arterial pressure, however, is not perfusion. Perfusion is determined by flow, and pressure and flow can separate, particularly where vascular tone is changing rapidly under the influence of anesthetic agents, surgical stimulation and vasoactive drugs. A recent prospective cohort in isolated coronary artery bypass grafting reported a mean of 86.4 minutes of low cardiac index across the whole operation, of which 69% occurred while the patient was normotensive, with a correlation between cardiac index and mean arterial pressure of only 0.33. Low cardiac output after cardiac surgery has itself been defined in at least 262 different ways, under which reported adult incidence ranges from 1.5% to 91%.

The interval that follows induction of anesthesia has a particular standing among these periods. It precedes surgical stimulation, it is short, and hemodynamic conditions within it are determined by anesthetic management alone. Post-induction hypotension has been characterized in detail and is conventionally measured over the first 20 minutes after induction. What happens to flow during this interval has not been described. This study sets out to characterize it.

STUDY DESIGN AND SETTING

This is a prospective, observational, two-centre cohort study conducted at two tertiary cardiovascular surgery centre. The study is observational in the strict sense: no aspect of anesthetic technique, monitoring, fluid or vasoactive management, or surgical conduct is altered for the purposes of the study, and the investigators take no part in clinical decisions. The study is reported in accordance with the STROBE statement.

Consecutive adults scheduled for isolated coronary artery bypass grafting with cardiopulmonary bypass are screened and enrolled. Patients are enrolled before induction of anesthesia so that baseline measurement can begin while they are awake.

HAEMODYNAMIC MONITORING AND DATA ACQUISITION

An arterial catheter is sited before induction while the patient is awake, in keeping with routine practice at both centre for this operation. Cardiac output is derived from the arterial waveform by pulse contour analysis via pressure recording analytical method and indexed to body surface area. Cardiac index is recorded continuously at 30-second intervals from before induction until the end of the operation.

Recorded at the same resolution are mean arterial pressure, systolic and diastolic pressure, heart rate, stroke volume and stroke volume index. Body surface area is computed once for each patient from height and weight.

The time of induction is recorded prospectively on the case report form as the moment at which the intravenous induction agent is given, and is cross-checked against the monitor clock. Where the two disagree, the discrepancy is documented and resolved before analysis by a prespecified rule.

THE ANALYSIS WINDOW

The analysis window is the 30 minutes that begin at induction of anesthesia. This length was chosen for two reasons. It extends beyond the 20 minutes over which post-induction hypotension is conventionally measured, so that the study can determine whether the conventional window is adequate for flow. It also ends before surgical stimulation is established in most patients, so that the exposure measured remains attributable to anesthetic management rather than to surgery.

The period of cardiopulmonary bypass is excluded from all analyses. Flow during bypass is generated by the pump rather than by the heart, so cardiac index derived from the arterial waveform has no physiological meaning in that interval. The bypass period is identified from the perfusion record and confirmed against the arterial waveform.

PRIMARY OUTCOME

The primary outcome has two components. Both are defined over the 30-minute window and both are referenced to a cardiac index threshold of 2.0 L/min/m2.

The first component is time below threshold: the total duration for which cardiac index lies below 2.0 L/min/m2, expressed in minutes.

The second component is cumulative low-output burden: the integral over time of the difference between the threshold and the measured cardiac index, taken only where that difference is positive. Formally, for threshold T and cardiac index CI(t), burden is the integral of the positive part of T minus CI(t) over the window.

The two components answer different questions and neither is sufficient alone. Time below threshold states how long the exposure lasted but is indifferent to its depth: one minute at 1.9 L/min/m2 and one minute at 1.0 L/min/m2 count equally. Cumulative burden states how deep the exposure was but is indifferent to its shape: a brief profound fall and a prolonged shallow one may yield the same value. Reported together they define the exposure.

The unit of burden reduces under dimensional analysis. Cardiac index is expressed in L/min/m2 and time in minutes, so their product is L/m2, a volume of undelivered flow indexed to body surface area. Multiplied by the patient's body surface area it becomes an absolute flow deficit expressed in litres, which is the quantity of blood flow that the circulation failed to deliver during the window.

Both components are computed between consecutive measurement pairs by the trapezoidal rule with linear interpolation, and threshold crossings are located exactly rather than rounded to the sampling grid. Intervals between consecutive measurements longer than the sampling period are not counted as observed time.

SECONDARY OUTCOMES

Time below threshold and cumulative burden are additionally computed at cardiac index thresholds of 2.2 and 2.5 L/min/m2 over the same window, so that the findings do not depend on a single threshold.

The incidence of PiLCOs is defined as the proportion of patients with at least one measurement below 2.0 L/min/m2 within the window.

Two measures of depth are reported. Time-weighted average depth is cumulative burden divided by the length of the window and describes the mean shortfall spread across the whole interval. Depth during exposure is the mean shortfall computed only over the time spent below threshold and describes how far below the threshold the circulation actually ran while the event was occurring.

The temporal distribution of exposure is described by the share of cumulative burden accruing within each of the three consecutive ten-minute segments of the window, and by the time from induction to the first measurement below threshold.

FLOW AND PRESSURE

A prespecified secondary analysis addresses whether pressure-based monitoring is able to detect the event. The proportion of sub-threshold exposure occurring while the patient is normotensive is quantified, a normotensive episode being defined as a cardiac index below 2.0 L/min/m2 recorded at a mean arterial pressure of 65 mmHg or above. The correlation between cardiac index and mean arterial pressure within the window is examined over the same period, and the agreement between the two in classifying a patient as exposed or unexposed is described.

EXPLORATORY ANALYSES

The association between the presence and the magnitude of PiLCOs and the postoperative course is examined for acute kidney injury, serum lactate, duration of mechanical ventilation, intensive care unit and hospital length of stay, and mortality. Patient-level and procedural characteristics, among them age, body-mass index, left ventricular ejection fraction, comorbidity burden, induction agent dose and cardiopulmonary bypass duration, are examined as correlates of exposure.

All outcome analyses are exploratory and hypothesis-generating. The number of covariates admitted to any model is constrained by the rule of at least ten events per variable, and no adjustment is made for multiple comparisons. Associations found here are intended to inform the design of subsequent studies rather than to establish causation.

STATISTICAL ANALYSIS

Continuous variables are summarized as mean and standard deviation where the distribution is symmetrical and as median and interquartile range where it is skewed. Distributional shape is assessed by the Shapiro-Wilk test together with bias-corrected coefficients of skewness and excess kurtosis, and uni-modality is examined using the bi-modality coefficient derived from those two moments. Confidence intervals for proportions are constructed by the Wilson score method and for means and medians by percentile bootstrap.

Groups are compared using the Mann-Whitney U test for continuous variables and Fisher's exact test for categorical variables. Effect size is reported as the Hodges-Lehmann estimate of location shift with its distribution-free confidence interval and as Cliff's delta for overlap. Associations between continuous variables are examined by Spearman rank correlation. A two-sided p value below 0.05 is taken as the threshold for statistical significance.

No value-based artifact filter is applied to the cardiac index record, and no measurement is excluded other than those flagged as invalid by the monitor itself. Removing low readings as artifact would cause systematic under-ascertainment of the very event under study.

Recording coverage within the window is quantified for each patient across the three ten-minute segments. A patient whose weighted coverage falls below a prespecified minimum is not included in the primary analysis, because the exposure cannot be estimated reliably from a sparse record.

SAMPLE SIZE

Sample size is based on the precision of estimation rather than on the power of a hypothesis test, because the study estimates the frequency and the magnitude of an event that has not previously been characterized rather than testing a prespecified superiority hypothesis.

An internal pilot of 30 patients, comprising the first 15 consecutive patients enrolled at each centre, was used to estimate variability. In that pilot the mean time below threshold was 6.59 minutes with a standard deviation of 8.14 minutes, and the incidence of PiLCOs was 70.0%.

Two precision targets were set. For mean time below threshold the half-width of the 95% confidence interval is to be no greater than 1.7 minutes, which requires 88 patients. For the incidence of PiLCOs the half-width is to be no greater than 9.5 percentage points, which requires 90 patients. The larger of the two figures was carried forward and rounded to 90, allocated as 45 patients per centre. Allowing 15% for withdrawal, protocol deviation and unusable recordings gives a planned enrollment of 103 patients.

ETHICS

The study is approved by the institutional review board at each participating centre and written informed consent is obtained from every patient before enrollment. Because the study imposes no intervention and alters no aspect of care, the risk to participants is confined to the handling of clinical data, which is stored in de-identified form.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age 18 years or older.
  • Scheduled for elective or emergency cardiac or non-cardiac surgery under general anesthesia.
  • Availability of peri-operative cardiac output monitoring using the MostCare hemodynamic monitoring system, starting before induction of anesthesia and continuing during surgery.
  • Availability of required baseline preoperative clinical and laboratory data.
  • Written informed consent obtained from the participant or legally authorized representative.

Exclusion criteria

  • Age under 18 years
  • Coronary artery bypass grafting combined with valve or aortic surgery
  • Preoperative mechanical circulatory support
  • Preoperative infusion of an inotrope or a vasopressor
  • Technical failure to establish arterial waveform monitoring before induction of anesthesia

Treatment and study plan

routine clinical monitoring, observed only

Other

routine clinical monitoring, observed only

Primary outcomes

  1. Time below threshold: total duration with a cardiac index below 2.0 L/min/m2, in minutes

    Time frame: From induction of anaesthesia to 30 minutes after induction

    The total duration for which cardiac index lies below 2.0 L/min/m2 during the analysis window, expressed in minutes. Cardiac index is recorded continuously at 30-second intervals by arterial waveform analysis. Duration is computed between consecutive measurement pairs by the trapezoidal rule with linear interpolation, and threshold crossings are located exactly rather than rounded to the sampling grid. Intervals between consecutive measurements longer than the sampling period are not counted as observed time. The period of cardiopulmonary bypass is excluded.

  2. Cumulative low-output burden: time integral of the cardiac index deficit below 2.0 L/min/m2, in L/m2

    Time frame: From induction of anaesthesia to 30 minutes after induction

    The integral over time of the difference between the threshold of 2.0 L/min/m2 and the measured cardiac index, taken only where that difference is positive, during the analysis window. Under dimensional analysis the unit reduces to L/m2, a volume of undelivered flow indexed to body surface area; multiplied by body surface area it yields an absolute flow deficit in litres. Computation, handling of gaps in the record, exclusion of the cardiopulmonary bypass period and the absence of artefact filtering are as described for time below threshold. Time below threshold states how long the exposure lasted and cumulative burden states how deep it was. The two are reported together because neither is sufficient alone.

Secondary outcomes

  1. Incidence of PiLCOs: proportion of patients with a cardiac index below 2.0 L/min/m2, in percent

    Time frame: From induction of anaesthesia to 30 minutes after induction

    The proportion of patients in whom cardiac index falls below 2.0 L/min/m2 on at least one occasion during the analysis window. A patient contributes to the numerator irrespective of how long the exposure lasts or how deep it is, so this measure describes how common the event is rather than how severe. The confidence interval is constructed by the Wilson score method.

  2. Time below threshold at a cardiac index of 2.2 L/min/m2, in minutes

    Time frame: From induction of anaesthesia to 30 minutes after induction

    The total duration for which cardiac index lies below 2.2 L/min/m2 during the analysis window, defined and computed exactly as for the primary outcome but at the higher threshold. Reported so that the findings do not depend on a single threshold.

  3. Cumulative low-output burden at a cardiac index of 2.2 L/min/m2, in L/m2

    Time frame: From induction of anaesthesia to 30 minutes after induction

    The integral over time of the difference between the threshold of 2.2 L/min/m2 and the measured cardiac index, taken only where that difference is positive, during the analysis window. Defined and computed exactly as for the primary outcome but at the higher threshold.

  4. Time below threshold at a cardiac index of 2.5 L/min/m2, in minutes

    Time frame: From induction of anaesthesia to 30 minutes after induction

    The total duration for which cardiac index lies below 2.5 L/min/m2 during the analysis window, defined and computed exactly as for the primary outcome but at the highest of the three thresholds.

  5. Cumulative low-output burden at a cardiac index of 2.5 L/min/m2, in L/m2

    Time frame: From induction of anaesthesia to 30 minutes after induction

    he integral over time of the difference between the threshold of 2.5 L/min/m2 and the measured cardiac index, taken only where that difference is positive, during the analysis window. Defined and computed exactly as for the primary outcome but at the highest of the three thresholds.

Other outcomes

  1. Postoperative acute kidney injury, in number of patients

    Time frame: Within 7 days after surgery

    Acute kidney injury after surgery, classified by the Kidney Disease Improving Global Outcomes criteria from serial serum creatinine measurements and urine output. Examined for association with the presence and the magnitude of PiLCOs. This analysis is exploratory and hypothesis-generating; the number of covariates admitted to any model is limited by the rule of at least ten events per variable and no adjustment is made for multiple comparisons.

  2. Peak postoperative serum lactate, in mmol/L

    Time frame: Within 24 hours after surgery

    The highest serum lactate concentration recorded after surgery, examined for association with the presence and the magnitude of PiLCOs. Exploratory.

  3. Duration of postoperative mechanical ventilation, in hours

    Time frame: From arrival in the intensive care unit to extubation, assessed up to 30 days

    The interval from arrival in the intensive care unit to extubation, examined for association with the presence and the magnitude of PiLCOs. Exploratory.

  4. Length of intensive care unit stay, in hours

    Time frame: From intensive care unit admission to discharge, assessed up to 30 days

    The interval from admission to the intensive care unit to discharge from it, examined for association with the presence and the magnitude of PiLCOs. Exploratory.

  5. Length of hospital stay, in days

    Time frame: From surgery to hospital discharge, assessed up to 30 days

    The interval from surgery to hospital discharge, examined for association with the presence and the magnitude of PiLCOs. Exploratory.

  6. All-cause mortality, in number of patients

    Time frame: Within 30 days after surgery

    Death from any cause within 30 days of surgery, examined for association with the presence and the magnitude of PiLCOs. Exploratory; the expected number of events in a cohort of this size is small and the analysis is not powered to detect an association.

Study contacts

Contact information is provided by the study sponsor or research team.

Muhammed Enes Aydin, Associate Professor

CONTACT

[email protected]

+905543318289

Sponsors and collaborators

Lead sponsor

Ataturk University

Other

Collaborators

  • Ankara City Hospital Bilkent

Registry information

Official study title

Post-Induction Low Cardiac Output Syndrome (PiLCOs): A Multicenter Prospective Observational Study to Identify Flow-Based Early Hypoperfusion in Coronary Artery Bypass Graft Surgical Patients

Acronym: PiLCOs

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
Sep 9, 2026
Registry last updated
Sep 9, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.